Subchronic oral toxicity of cyclopiazonic acid (CPA) in male Sprague-Dawley rats

1990 ◽  
Vol 110 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Kenneth A. Voss ◽  
William P. Norred ◽  
Dorothy M. Hinton ◽  
Richard J. Cole ◽  
Joe W. Dorner
2020 ◽  
Vol 7 ◽  
pp. 1616-1621
Author(s):  
Mahedi Hasan ◽  
Abdullah Al Mahmud ◽  
Md. Jahir Alam ◽  
Shafayet Ahmed Siddiqui ◽  
Md. Saiful Islam Arman ◽  
...  

2013 ◽  
Vol 32 (5) ◽  
pp. 385-394 ◽  
Author(s):  
Antoinette Y. Odendaal ◽  
Narendra S. Deshmukh ◽  
Tennille K. Marx ◽  
Alexander G. Schauss ◽  
John R. Endres ◽  
...  

This toxicological assessment evaluated the safety of a hydroethanolic extract prepared from Caralluma fimbriata (CFE), a dietary supplement marketed worldwide as an appetite suppressant. Studies included 2 in vitro genotoxicity assays, a repeated dose oral toxicity study, and a developmental study in rats. No evidence of in vitro mutagenicity or clastogenicity surfaced in the in vitro studies at concentrations up to 5000 μg of extract/plate (Ames test) or 5000 μg of extract/mL (chromosomal aberration test). No deaths or treatment-related toxicity were seen in the 6-month chronic oral toxicity study in Sprague-Dawley rats conducted at 3 doses (100, 300, and 1000 mg/kg body weight (bw)/d). The no observed effect level for CFE in this study was considered to be 1000 mg/kg bw/d. A prenatal developmental toxicity study conducted at 3 doses (250, 500, and 1000 mg/kg bw/d) in female Sprague-Dawley rats resulted in no treatment-related external, visceral, or skeletal fetal abnormalities, and no treatment-related maternal or pregnancy alterations were seen at and up to the maximum dose tested. CFE was not associated with any toxicity or adverse events.


2010 ◽  
Vol 196 ◽  
pp. S269-S270
Author(s):  
R. Gámez ◽  
A. Gutiérrez ◽  
D.F. Arencibia ◽  
B. Pardo ◽  
M. Noa ◽  
...  

Author(s):  
Saad Alkahtani ◽  
Md Saquib Hasnain ◽  
Hamzah Algamdy ◽  
Nada H. Aljarba ◽  
Abdullah AlKahtane

2016 ◽  
Vol 81 ◽  
pp. 275-283 ◽  
Author(s):  
A.M. Saillenfait ◽  
F. Marquet ◽  
J.P. Sabaté ◽  
D. Ndiaye ◽  
A.M. Lambert-Xolin

2018 ◽  
Vol 34 (2) ◽  
pp. 85-95 ◽  
Author(s):  
Syahirah Ahmad Sayuti Nurul ◽  
Hamzah Hazilawati ◽  
Rosly Shaari Mohd ◽  
Farhan Hanif Reduan Mohd ◽  
Mohamed Mustapha Noordin ◽  
...  

2015 ◽  
Vol 34 (1) ◽  
pp. 55-66 ◽  
Author(s):  
Lee C. B. Crouse ◽  
Emily May Lent ◽  
Glenn J. Leach

3-Nitro-1,2,4-triazol-5-one (NTO), an insensitive explosive, was evaluated to assess potential environmental and human health effects. A 14-day oral toxicity study in Sprague-Dawley rats was conducted with NTO in polyethylene glycol -200 by gavage at doses of 0, 250, 500, 1000, 1500, or 2000 mg/kg-d. Body mass and food consumption decreased in males (2000 mg/kg-d), and testes mass was reduced at doses of 500 mg/kg-d and greater. Based on the findings in the 14-day study, a 90-day study was conducted at doses of 0, 30, 100, 315, or 1000 mg/kg-d NTO. There was no effect on food consumption, body mass, or neurobehavioral parameters. Males in the 315 and 1000 mg/kg-d groups had reduced testes mass with associated tubular degeneration and atrophy. The testicular effects were the most sensitive adverse effect and were used to derive a benchmark dose (BMD) of 70 mg/kg-d with a 10% effect level (BMDL10) of 40 mg/kg-d.


2014 ◽  
Vol 9 (5) ◽  
pp. 603-612 ◽  
Author(s):  
Jae Hyuck Sung ◽  
Soo Jin Park ◽  
Min Sook Jeong ◽  
Kyung Seuk Song ◽  
Kyu Sup Ahn ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document